Analyst Research

Report Title Price
Wright Investors Service Comprehensive Report for Dexcom, Inc.
Provider: Wright Reports
$472.00
Buy
DEXCOM INC (DXCM) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
DexCom Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - DEXCOM, INC. (DXCM-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

DexCom Inc Receives CE Mark Approval For Dexcom G4 Continuous Glucose Monitoring System


Thursday, 14 Jun 2012 08:30am EDT 

DexCom Inc announced that it has received CE Mark (Conformité Européene) approval for fourth generation continuous glucose monitoring system, the Dexcom G4 system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark. 

Latest Developments for DexCom Inc

Latest Key Developments in Medical

Company Quote

DexCom Inc
(DXCM.OQ)
21.18
1.73 +8.89%
17 May 2013